Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEBPA |
| Upstream (Parents) |
|---|
| (<<) BDH1 → CEBPA |
| (<<) GRHPR → CEBPA |
| (<<) HSD11B1 → CEBPA |
| (<<) LTA4H → CEBPA |
| (<<) MAFF → CEBPA |
| (<<) PCK2 → CEBPA |
| (<<) SOX9 → CEBPA |
| (<<) TSPAN3 → CEBPA |
| Downstream (Children) |
|---|
| CEBPA → ADAM9 (>>) |
| CEBPA → DUSP4 (>>) |
| CEBPA → FZD8 (>>) |
| CEBPA → HDAC4 (>>) |
| CEBPA → HMGCR (>>) |
| CEBPA → ME1 (>>) |
| CEBPA → NFAT5 (>>) |
| CEBPA → NGFR (>>) |
| CEBPA → PHLDA1 (>>) |
| CEBPA → PRSS2 (>>) |
| CEBPA → RB1 (>>) |
| CEBPA → RNF5 (>>) |
| CEBPA → SEH1L (>>) |
| CEBPA → TAF1A (>>) |
| CEBPA → TFF1 (>>) |
